A model for neutralization of viruses based on antibody coating of the virion surface.

[1]  R. Compans,et al.  Effect of the Cytoplasmic Domain of the Simian Immunodeficiency Virus Envelope Protein on Incorporation of Heterologous Envelope Proteins and Sensitivity to Neutralization , 2000, Journal of Virology.

[2]  D. Burton,et al.  Antibody and virus: binding and neutralization. , 2000, Virology.

[3]  T. Hackstadt,et al.  Ultrastructural Analysis of Developmental Events inChlamydia pneumoniae-Infected Cells , 2000, Infection and Immunity.

[4]  D. Burton,et al.  Vaccines and the induction of functional antibodies: Time to look beyond the molecules of natural infection? , 2000, Nature Medicine.

[5]  B L Trus,et al.  Three-dimensional structure of poliovirus receptor bound to poliovirus. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M G Rossmann,et al.  Interaction of the poliovirus receptor with poliovirus. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  K. Schønning,et al.  Stoichiometry of Monoclonal Antibody Neutralization of T-Cell Line-Adapted Human Immunodeficiency Virus Type 1 , 1999, Journal of Virology.

[8]  Mccullough Kc,et al.  Rapidity of specific antibody-antigen interactions. , 1999 .

[9]  Damien Fleury,et al.  A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site , 1999, Nature Structural Biology.

[10]  K. Conzelmann,et al.  Monoclonal antibodies to the GP5 of porcine reproductive and respiratory syndrome virus are more effective in virus neutralization than monoclonal antibodies to the GP4. , 1999, Veterinary microbiology.

[11]  H. Guy,et al.  Epitope Mapping of CCR5 Reveals Multiple Conformational States and Distinct but Overlapping Structures Involved in Chemokine and Coreceptor Function* , 1999, The Journal of Biological Chemistry.

[12]  D. Burton,et al.  Human Antibody Responses to Mature and Immature Forms of Viral Envelope in Respiratory Syncytial Virus Infection: Significance for Subunit Vaccines , 1999, Journal of Virology.

[13]  M. Aikawa,et al.  Immunocytochemical Colocalization of Specific Immunoglobulin A with Sendai Virus Protein in Infected Polarized Epithelium , 1998, The Journal of experimental medicine.

[14]  G. Spear,et al.  Complement can neutralize HIV-1 plasma virus by a C5-independent mechanism. , 1998, Virology.

[15]  B. Trus,et al.  Two antibodies that neutralize papillomavirus by different mechanisms show distinct binding patterns at 13 A resolution. , 1998, Journal of molecular biology.

[16]  C. Barbas,et al.  Determinants of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Activation by Soluble CD4 and Monoclonal Antibodies , 1998, Journal of Virology.

[17]  C. Dupont,et al.  Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. , 1998, Immunity.

[18]  Wai-ming Lee,et al.  Antibody-Mediated Neutralization of Human Rhinovirus 14 Explored by Means of Cryoelectron Microscopy and X-Ray Crystallography of Virus-Fab Complexes , 1998, Journal of Virology.

[19]  Q. Sattentau,et al.  Neutralization of Human Immunodeficiency Virus Type 1 by Antibody to gp120 Is Determined Primarily by Occupancy of Sites on the Virion Irrespective of Epitope Specificity , 1998, Journal of Virology.

[20]  Q. Sattentau,et al.  Inhibition of Virus Attachment to CD4+ Target Cells Is a Major Mechanism of T Cell Line–adapted HIV-1 Neutralization , 1997, The Journal of experimental medicine.

[21]  Geoffrey L. Smith,et al.  Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation. , 1997, The Journal of general virology.

[22]  N. Thielens,et al.  Two parallel routes of the complement‐mediated antibody‐dependent enhancement of HIV‐1 infection , 1997, AIDS.

[23]  J. Sodroski,et al.  Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization , 1997, Journal of virology.

[24]  P. Stewart,et al.  Recent structural solutions for antibody neutralization of viruses. , 1997, Trends in microbiology.

[25]  W. Hendrickson,et al.  Dimeric association and segmental variability in the structure of human CD4 , 1997, Nature.

[26]  Q. Sattentau,et al.  HIV-1 antibody — debris or virion? , 1997, Nature Medicine.

[27]  P L Stewart,et al.  Cryo‐EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization , 1997, The EMBO journal.

[28]  G. Spear,et al.  Detection of HLA-DR associated with monocytotropic, primary, and plasma isolates of human immunodeficiency virus type 1 , 1997, Journal of virology.

[29]  Timothy S. Baker,et al.  Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon , 1996, Nature.

[30]  J. Sodroski,et al.  Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses , 1996, Journal of virology.

[31]  J. Moore,et al.  Quantitative model of antibody- and soluble CD4-mediated neutralization of primary isolates and T-cell line-adapted strains of human immunodeficiency virus type 1 , 1996, Journal of virology.

[32]  D. Blaas,et al.  Structure of a neutralizing antibody bound bivalently to human rhinovirus 2. , 1996, The EMBO journal.

[33]  M. Sanner,et al.  Reduced surface: an efficient way to compute molecular surfaces. , 1996, Biopolymers.

[34]  W. Britt,et al.  Human cytomegalovirus neutralizing antibody-resistant phenotype is associated with reduced expression of glycoprotein H , 1995, Journal of virology.

[35]  H. Raux,et al.  Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing. , 1995, Virology.

[36]  Q. Sattentau,et al.  Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer , 1995, The Journal of experimental medicine.

[37]  Ying Sun,et al.  Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates , 1995, Journal of virology.

[38]  J. Strominger,et al.  Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus , 1995, Journal of virology.

[39]  J. Hansen,et al.  Increased adhesion as a mechanism of antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus infection , 1995, Journal of virology.

[40]  M. Mazanec,et al.  Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies , 1995, Journal of virology.

[41]  Q. Sattentau,et al.  Epitope exposure on functional, oligomeric HIV-1 gp41 molecules. , 1995, Virology.

[42]  C. Barbas,et al.  Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120 , 1995, Journal of virology.

[43]  M. Schutten,et al.  Enhancement of Infectivity of a Non‐Syncytium Inducing HIV‐1 by sCD4 and by Human Antibodies that Neutralize Syncytium Inducing HIV‐1 , 1995, Scandinavian journal of immunology.

[44]  Darren W. Henderson,et al.  Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins , 1994, Journal of virology.

[45]  D R Burton,et al.  Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1 , 1994, Journal of virology.

[46]  A. Prince.  Challenges for development of hepatitis C virus vaccines. , 1994, FEMS microbiology reviews.

[47]  N. Dimmock,et al.  Single- and multi-hit kinetics of immunoglobulin G neutralization of human immunodeficiency virus type 1 by monoclonal antibodies. , 1994, The Journal of general virology.

[48]  C. Castilletti,et al.  A simple and reliable method to detect cell membrane proteins on infectious human immunodeficiency virus type 1 particles. , 1994, The Journal of infectious diseases.

[49]  S. Halstead,et al.  Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials. , 1993, AIDS research and human retroviruses.

[50]  R. Orentas,et al.  Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. , 1993, AIDS research and human retroviruses.

[51]  R. Ruigrok,et al.  Mechanisms of rabies virus neutralization. , 1993, Virology.

[52]  T S Baker,et al.  Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody , 1993, Journal of virology.

[53]  L. Arthur,et al.  Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. , 1992, Science.

[54]  M. Kazatchkine,et al.  Complement Receptor Type 2 Mediates Infection of the Human CD4‐Negative Raji B‐Cell Line with Opsonized HIV , 1992, Scandinavian journal of immunology.

[55]  A. Portner,et al.  Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract. , 1992, Virus research.

[56]  R. Peeling,et al.  Neutralization of Chlamydia trachomatis: kinetics and stoichiometry , 1991, Infection and immunity.

[57]  H. Gelderblom.  Assembly and morphology of HIV: potential effect of structure on viral function. , 1991, AIDS.

[58]  Q. Sattentau,et al.  A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion. , 1991, The Journal of biological chemistry.

[59]  Q. Sattentau,et al.  Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding , 1990, The Journal of experimental medicine.

[60]  J. Levy,et al.  The FC and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. , 1989, Disease markers.

[61]  Q. Sattentau,et al.  Identification of the residues in human CD4 critical for the binding of HIV , 1989, Cell.

[62]  J. Tomassini,et al.  Inhibition of rhinovirus attachment by neutralizing monoclonal antibodies and their Fab fragments , 1989, Journal of virology.

[63]  F. Ennis,et al.  Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. , 1988, Science.

[64]  K. McCullough,et al.  Opsonization-enhanced phagocytosis of foot-and-mouth disease virus. , 1988, Immunology.

[65]  R. Johnston,et al.  Antibody-mediated activation of Sindbis virus. , 1988, Virology.

[66]  R. Lamb,et al.  Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions , 1988, Journal of virology.

[67]  K. Steimer,et al.  Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4 , 1988, Nature.

[68]  D. Montefiori,et al.  ANTIBODY-DEPENDENT ENHANCEMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION , 1988, The Lancet.

[69]  G. Pauli,et al.  MHC-Antigens: Constituents of the Envelopes of Human and Simian Immunodeficiency , 1987, Zeitschrift fur Naturforschung. C, Journal of biosciences.

[70]  S. Halstead,et al.  Profiles of antibody-dependent enhancement of dengue virus type 2 infection. , 1987, Microbial pathogenesis.

[71]  N. Dimmock,et al.  Quantitative relationships between an influenza virus and neutralizing antibody. , 1987, Virology.

[72]  Q. Sattentau,et al.  Epitopes of the CD4 antigen and HIV infection. , 1986, Science.

[73]  R. Crainic,et al.  Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site , 1986, Journal of virology.

[74]  S. Lemon,et al.  Incomplete neutralization of hepatitis A virus in vitro due to lipid-associated virions. , 1985, The Journal of general virology.

[75]  S. Kuge,et al.  Antigenic variation and resistance to neutralization in poliovirus type 1. , 1985, Science.

[76]  A. Thomas,et al.  Lack of quantitative correlation between the neutralization of poliovirus and the antibody-mediated pI shift of the virions. , 1985, The Journal of general virology.

[77]  R. M. Iorio,et al.  Neutralization of Newcastle disease virus by monoclonal antibodies to the hemagglutinin-neuraminidase glycoprotein: requirement for antibodies to four sites for complete neutralization , 1984, Journal of virology.

[78]  L. Kingsford.  Enhanced neutralization of La Crosse virus by the binding of specific pairs of monoclonal antibodies to the G1 glycoprotein. , 1984, Virology.

[79]  R. M. Iorio,et al.  Monoclonal antibodies to newcastle disease virus: delineation of four epitopes on the HN glycoprotein , 1983, Journal of virology.

[80]  E. Wimmer,et al.  Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization , 1983, Journal of virology.

[81]  R. Crainic,et al.  Natural variation of poliovirus neutralization epitopes , 1983, Infection and immunity.

[82]  R. Rueckert,et al.  Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry. , 1983, Virology.

[83]  E. Wimmer,et al.  Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies , 1983, Journal of virology.

[84]  M. Essex,et al.  Neutralization of feline leukemia virus with feline antisera to leukocyte alloantigens. , 1982, Cancer research.

[85]  G. Schild,et al.  Studies on the mechanism of neutralization of influenza virus by antibody: evidence that neutralizing antibody (anti-haemagglutinin) inactivates influenza virus in vivo by inhibiting virion transcriptase activity. , 1982, The Journal of general virology.

[86]  G. Schochetman,et al.  Viral epitopes and monoclonal antibodies: isolation of blocking antibodies that inhibit virus neutralization. , 1981, Science.

[87]  A. Scheid,et al.  Immunological studies of the functions of paramyxovirus glycoproteins. , 1981, Virology.

[88]  B. Mandel.  Neutralization of poliovirus: a hypothesis to explain the mechanism and the one-hit character of the neutralization reaction. , 1976, Virology.

[89]  F. Cathala,et al.  Vesicular stomatitis virus (measles) pseudotypes: tool for demonstrating defective measles infections. , 1975, Intervirology.

[90]  Y. Kimura.  Phenotypic mixing of vesicular stomatitis virus with HVJ (Sendai virus). , 1973, Japanese journal of microbiology.

[91]  B. A. Rubin,et al.  Electron microscopic studies on the structure of rabies virus. , 1972, Journal of ultrastructure research.

[92]  R. Chanock,et al.  Association of serum anti-neuraminidase antibody with resistance to influenza in man. , 1972, The New England journal of medicine.

[93]  J. Závada,et al.  Phenotypic mixing of vesicular stomatitis virus with fowl plague virus. , 1972, Acta virologica.

[94]  C. Wallis,et al.  Herpesvirus neutralization: induction of the persistent fraction by insufficient antibody. , 1970, Virology.

[95]  J. Uhr,et al.  A mathematical and experimental study of the kinetics of neutralization of bacteriophage phi chi 174 by antibodies. , 1969, Journal of immunology.

[96]  A. Notkins,et al.  Kinetics of neutralization of sensitized herpes simplex virus with antibody fragments. , 1969, Virology.

[97]  R. Webster,et al.  Antiviral Activity of Antiserum Specific for an Influenza Virus Neuraminidase , 1968, Journal of virology.

[98]  A. Notkins,et al.  Kinetics of sensitization of herpes simplex virus and its relationship to the reduction in the neutralization rate constant. , 1967, Virology.

[99]  K. Lafferty,et al.  The enhancement of virus infectivity by antibody , 1967 .

[100]  R. Webster,et al.  Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus. , 1967, Journal of immunology.

[101]  C. Wallis,et al.  Virus Aggregation as the Cause of the Non-neutralizable Persistent Fraction , 1967, Journal of virology.

[102]  E. G. Westaway.  The neutralization of arboviruses. I. Neutralization homologous virus-serum mixtures with two group B arboviruses. , 1965, Virology.

[103]  K. Lafferty.  THE INTERACTION BETWEEN VIRUS AND ANTIBODY. II. MECHANISM OF THE REACTION. , 1963, Virology.

[104]  K. Lafferty.  THE INTERACTION BETWEEN VIRUS AND ANTIBODY. I. KINETIC STUDIES. , 1963, Virology.

[105]  B. Mandel.  Reversibility of the reaction between polio-virus and neutralizing antibody of rabbit origin. , 1961, Virology.

[106]  R. Dulbecco,et al.  A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus. , 1956, Virology.

[107]  N. K. Jerne,et al.  The development of the phage-inactivating properties of serum during the course of specific immunization of an animal: reversible and irreversible inactivation. , 1956, Journal of immunology.

[108]  D. Blaas,et al.  Structural studies on antibody interacting with viruses. , 2001, Current topics in microbiology and immunology.

[109]  V. Racaniello.  Picornaviridae : the viruses and their replication , 2001 .

[110]  J. Skehel,et al.  Structural studies on viral escape from antibody neutralization. , 2001, Current topics in microbiology and immunology.

[111]  T. Smith,et al.  Antibody interactions with rhinovirus: lessons for mechanisms of neutralization and the role of immunity in viral evolution. , 2001, Current topics in microbiology and immunology.

[112]  J. Mcghee,et al.  Role of mucosal antibodies in viral infections. , 2001, Current topics in microbiology and immunology.

[113]  Q. Sattentau,et al.  The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity. , 1999, AIDS.

[114]  Berger Ea.  HIV entry and tropism: the chemokine receptor connection. , 1997 .

[115]  J. Moore,et al.  HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells. , 1995, AIDS.

[116]  E. Stott.  Towards a vaccine against AIDS: lessons from simian immunodeficiency virus vaccines. , 1994, Current topics in microbiology and immunology.

[117]  J. Hoxie,et al.  Nonrandom association of cellular antigens with HTLV-III virions. , 1987, Human immunology.

[118]  S. Halstead,et al.  Immune enhancement of viral infection. , 1982, Progress in allergy.

[119]  E. G. Westaway,et al.  A multi-hit model for the neutralization of animal viruses. , 1978, The Journal of general virology.

[120]  Oldstone Mb.  Virus neutralization and virus-induced immune complex disease. Virus-antibody union resulting in immunoprotection or immunologic injury--two sides of the same coin. , 1975, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.

[121]  I. Rappaport.  An analysis of the inactivation of MS2 bacteriophage with antiserum. , 1970, The Journal of general virology.

[122]  L. Philipson,et al.  Interaction between poliovirus and immunoglobulins. I. Detection of virus antibodies by partition in aqueous polymer phase systems. , 1966, Virology.

[123]  L. Philipson.  Interaction between poliovirus and immunoglobulins. II. Basic aspects of virus-antibody interaction. , 1966 .

[124]  F. Burnet,et al.  Immunological Reactions of the Filterable Viruses , 1938, Nature.